Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, August 1998, p. 1906-1910, Vol. 42, No. 8
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Generation of Bioluminescent Streptococcus
mutans and Its Usage in Rapid Analysis of the Efficacy of
Antimicrobial Compounds
Vuokko
Loimaranta,1,*
Jorma
Tenovuo,1
Leeni
Koivisto,2,
and
Matti
Karp2
Institute of Dentistry and Turku Immunology
Centre1 and
Department of
Biotechnology,2 University of Turku,
FIN-20520 Turku, Finland
Received 30 September 1997/Returned for modification 31 January
1998/Accepted 27 April 1998
 |
ABSTRACT |
The oral bacterium Streptococcus mutans was transformed
by electroporation with a shuttle vector (pCSS945) containing insect luciferase gene from a click beetle (Pyrophorus
plagiophthalamus) resulting in a bioluminescent phenotype. This
S. mutans strain was used in experiments in which light
emission was used as a rapid and, compared to conventional CFU
counting, more convenient means of estimating the effects of various
antimicrobial treatments. The basic parameters affecting in vivo light
production by the strain were studied. It was found that pH 6.0 was
optimal for incorporation of the substrate D-luciferin for
the luciferase reaction. The optimum concentration of
D-luciferin was approximately 150 µM at room temperature.
Under optimum conditions the light emission in vivo increased
rapidly to a constant level and thereafter had a decay of 0.6%/min
when logarithmic-growth-phase cells were used. The light emission
closely paralleled the numbers of CFU, giving a detectable signal from
30,000 cells and having a dynamic measurement range over 4 log
CFU/relative light unit. The cells were treated with various
antimicrobial agents, and the emitted bioluminescence was
measured. With the bioluminescent measurements, the results were
obtained within hours compared to the days required for agar plates,
and also, the kinetics of the antibacterial actions could be followed.
Thus, the light emission was found to be a reliable, sensitive, and
real-time indicator of the bacteriostatic actions of the antimicrobial
agents tested.
 |
INTRODUCTION |
The gram-positive oral streptococcus
Streptococcus mutans is considered the most important
cariogenic species in the human oral microbial flora (for a review, see
reference 21). Due to the role of this microorganism
in the formation of caries lesions, there is constant interest in the
antistreptococcal effects of a wide variety of substances, such as
antibiotics and oral hygiene products. In our laboratory the
susceptibility of S. mutans to innate salivary
antimicrobial proteins (lysozyme, lactoferrin, and the peroxidase
system of proteins) and the combined effects of these innate factors
with immunoglobulin A (IgA) or other antibacterial agents such as
fluoride have been studied (19, 20, 22, 25, 28). All such
studies generally require methods like plate dilution, which is
laborious and time-consuming, especially with mutans group
streptococci, for which growth on agar plates normally takes several
days.
Insect luciferase is an enzyme produced by, for instance, the Jamaican
click beetle (Pyrophorus plagiophthalamus) (24)
or the North American firefly (Photinus pyralis)
(23). This enzyme uses D-luciferin,
O2, and ATP as substrates and produces AMP, oxyluciferin,
inorganic pyrophosphate, water, and light (547 to 617 nm) as end
products (1). The gene coding for the green light-emitting
luciferase from the click beetle has been expressed in
Escherichia coli (32) and in insect
Spodoptera frugiperda cells (10). The gene for
the better-known homolog firefly luciferase already has an established
record of being a standard in reporter gene studies and has therefore
been expressed in a wide variety of hosts from procaryotic to
eucaryotic cells (for a recent review, see reference
8). In each case the new host for the genes was able
to produce light which could be very sensitively measured. Therefore,
many applications for luminescent cells have been created during the
last few years, for instance, an assay for the extremely sensitive
detection of the drug susceptibility of Mycobacterium tuberculosis (9). We have used bacteria cloned either
with bacterial luciferase (lux) genes or with insect
luciferase (luc) genes as general detectors of toxic
substances (17), in studies concerning the killing of
E. coli cells with nitric oxide-donating chemicals
(29), and for the specific detection of heavy metals such as
mercuric ions (30).
Due to its linkage to ATP metabolism, luciferase activity in vivo is a
good indicator of the intracellular state of cells. In this report we
describe the formation of light-emitting S. mutans
obtained by transforming the bacteria with a shuttle vector (pCSS945)
containing the luciferase gene from P. plagiophtalamus for the fast and sensitive measurement of antibacterial activity. The
conditions affecting the light emission of the transformed bacteria and
the suitability of using bioluminescent S. mutans to
obtain antimicrobial activity measurements are also examined.
 |
MATERIALS AND METHODS |
Bacterial strains, plasmids, and reagents.
The bacterial
strains and plasmids used in this study are listed in Table
1. All enzymes used in the study except
calf intestinal alkaline phosphatase (CIP) were from New England
Biolabs (Beverly, Mass.); CIP was from Pharmacia (Uppsala, Sweden). The
growth media brain heart infusion (BHI) broth and mitis salivarius agar
were from Oxoid (Basingstoke, United Kingdom), and tryptone and yeast extract were from Difco Laboratories (Detroit, Mich.). The antibiotics that we tested were from Sigma (St. Louis, Mo.).
Plasmid constructions.
Plasmid pCSS945 containing the
luciferase gene from a click beetle (P. plagiophthalamus) was constructed as follows. Plasmid pLucGR
(tac) (33) was digested with the restriction
enzyme BspHI and filled in with deoxynucleotides and the
Klenow fragment of DNA polymerase I. The 1.6-kb DNA fragment was
ligated with T4 DNA ligase to the vector p602/22, which was first
digested with the restriction enzyme BamHI, and treated with
the Klenow enzyme, deoxynucleotides, and CIP. The resulting vector
contained the lucGR gene of P. plagiophthalamus under the control of a strong phage T5 promoter
and lac operator.
The promoter-operator-luciferase fragment was excised with restriction
enzymes XhoI and HindIII, filled in with
Klenow enzyme and deoxynucleotides, and ligated to the vector pGK13
which was cut with HindIII, filled in with the Klenow
fragment and deoxynucleotides, and treated with CIP. Plasmid pGK13
(27) is a derivative of pGK12. Plasmid pGK13 contains both
erythromycin and chloramphenicol resistance markers, like the parent
plasmid pGK12, and it has been shown to transform Streptococcus
sanguis and Streptococcus pyogenes to erythromycin
resistance (27). The ligation mixtures were introduced into
electrocompetent E. coli MC1061 cells by electroporation (4) and plated onto L-agar plates (10 g of tryptone, 5 g of yeast extract, 5 g of NaCl, and 15 g of
agar in 1 liter) containing chloramphenicol (10 µg/ml). Plasmid
minipreparations were made from several colonies and were verified for
expected structure by restriction enzyme digestions. One correct
structure was named pCSS945.
Transformation.
S. mutans NCTC 10449 cells were
transformed with vector pCSS945 by electroporation as follows. The
cells were cultivated in BHI broth to an optical density (OD) at 600 nm
(OD600) of 0.6, centrifuged at 4,000 × g
at 4°C for 15 min, washed twice with ice-cold buffer (10 mM HEPES
buffer [pH 7.0] with 15% glycerol), and suspended in 5% sucrose
containing 15% glycerol. The electroporation was performed in Bio-Rad
(Richmond, Calif.) electroporation cuvettes with a 0.1-cm distance
between electrodes with 1 µl of plasmid (10 ng) and 40 µl of
ice-cold electrocompetent cells. A single electric pulse of 4.5 ms with
settings of 1.25 kV, 25 µF, and 200
was given, and the cells were
then rapidly removed from the electroporation apparatus (Bio-Rad) and
suspended in 960 µl of BHI broth. After 1 h the cells were
plated onto mitis salivarius agar plates containing 10 µg of
chloramphenicol and grown for 2 days at 35°C.
Light emission measurements.
Light emission from growing
S. mutans cells was measured in vivo by adding 50 µl
of substrate solution (1 mM D-luciferin in 0.1 M sodium
citrate buffer [pH 5.0]) to 200 µl of cells in a luminometer
cuvette. After the addition of substrate solution the cuvette was
immediately placed in a manual tube luminometer (1250; LKB-Wallac,
Turku, Finland), and light emission was recorded on a chart recorder
(LKB-Bromma, Stockholm, Sweden). Some of the light emission
measurements were performed with a 96-well microtitration plate
luminometer (Luminoscan, Labsystems, Finland) by using a constant
measurement mode. If not otherwise stated, all the bioluminescence measurements were performed at room temperature (RT; 20 to 24°C). The
light emission as a function of the amount of cells was studied by
making dilutions of cell suspensions and measuring both bioluminescence and the numbers of CFU from the samples. To see whether the light emission remains stable for longer periods of time, washed
logarithmic-phase cells were stored in buffer (10 mM phosphate buffer
containing 74 mM NaCl, 6 mM KCl, 2 mM CaCl2, 0.5 mM
MgCl2, 0.5 mM NH4Cl, and 1 g of glucose
per liter [pH 6.5]) at different temperatures (0 and 4°C, RT, and
30°C), and the light emission was measured from aliquots withdrawn
during 8 h of incubation.
Various parameters were studied for optimized light emission in vivo
for S. mutans. The effect of pH was studied by adding a
constant amount (500 µM) of D-luciferin to 0.1 M
phosphate-citrate buffer adjusted to different pHs ranging from 4.5 to
7.0. The bioluminescence reaction was started by adding 100 µl of
substrate buffer to a 100-µl sample of living S. mutans cells. The effects of different amounts of
D-luciferin at different pHs were studied similarly by
using final D-luciferin concentrations of from 5 to 250 µM.
Testing of antimicrobial agents.
Twofold dilution series
were made from all tested antimicrobial agents: chlorhexidine,
tetracycline, and penicillin G starting from 10, 0.8, and 0.4 µg/ml,
respectively. The bacteria were cultivated to the logarithmic phase and
were washed twice with 0.9% saline. To prevent the decrease in
bioluminescence due to incubation time and temperature and to create an
environment similar to that in the agar plate experiments (see below),
the bacteria were finally suspended in BHI broth to approximately
107 cells/ml. A 25-µl sample of this cell suspension, 100 µl of the appropriate antimicrobial dilution, and 25 µl of 1 mM
D-luciferin were added to the wells of microtiter plates.
The plates were incubated at 35°C, and the emitted light was measured
after 0, 1, 2, 3, and 4 h with a 1450 Microbeta plus liquid
scintillation counter (Wallac, Turku, Finland). The same dilutions of
antimicrobial agents were also used to test for growth inhibition on
agar plates. An aliquot of 20 µl of a solution of logarithmic-phase
bacteria was spread evenly onto a BHI agar plate, and pieces of glass
fiber filters containing the antimicrobial solution or 0.9% NaCl for the controls were placed on the bacteria. After 48 h at 35°C the growth inhibition was visually examined.
 |
RESULTS |
Light emission measurements.
Expression of the luc
gene is controlled by a constitutive phage T5 promoter which was found
to work in S. mutans, and the light emission measured
as a function of cell growth is shown in Fig.
1. The bioluminescence closely correlates
with the OD of the culture and also with the cell number over a 4-log
range (Fig. 2). The bacterial cells could
be stored in buffer for at least 8 h at 4°C without notable
changes in light emission, whereas at RT and 30°C the bioluminescence
decreased 29 and 62%, respectively, after 1 h of incubation
(Table 2).

View larger version (39K):
[in this window]
[in a new window]
|
FIG. 1.
Growth curve for recombinant S. mutans
as a function of time and bioluminescence. The growth of S. mutans cells in BHI broth containing 10 µg of chloramphenicol
per ml was followed with a spectrophotometer (OD600; curve)
and a manual luminometer (relative light units [RLU]; bars) after the
addition of D-luciferin at 200 µM and pH 5.0. The values
are means of two independent experiments. The variation between the
measurements was less than 10%.
|
|

View larger version (13K):
[in this window]
[in a new window]
|
FIG. 2.
Linear relationship between amount of cells and the
bioluminescence that was produced. Samples from logarithmic-phase
bacteria were serially diluted, and light emission (relative light
units [RLU]) was determined after the addition of 200 µM
D-luciferin. From the same samples the numbers of CFU were
also calculated on agar plates. Each symbol represents the results of
one independent experiment.
|
|
As seen in Fig. 3, pH has a strong effect
on the light emission of logarithmic-phase bacteria and pH 6.0 gives
the highest emission, with a decay of light of 0.6%/min. Saturating
levels of substrate were obtained at about 125 µM for all pHs tested (5.5, 6.0, and 6.5), and again, the cells gave the highest light emission at pH 6.0 (Table 3). The
kinetics of light emission of logarithmic-growth-phase cells as a
function of the D-luciferin concentration at pH 6.0 are
presented in Fig. 4. The kinetics were
affected by the growth phase. The decay times became faster as the
cells became older (data not shown).

View larger version (24K):
[in this window]
[in a new window]
|
FIG. 3.
Light emission as a function of time and pH. The
bioluminescence (in relative light units [RLU]) of logarithmic-phase
S. mutans cells was measured at pH 4.5 ( ), 5.0 (*), 5.5 (×), 6.0 ( ), 6.5 ( ), and 7.0 ( ) after the addition
of 200 µM D-luciferin (a). (b) Peak relative light units
as a function of pH. For details, see Materials and Methods. The values
are the means of two independent measurements. The variation between
the measurements was less than 10%.
|
|

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 4.
Decay of light emission of logarithmic-phase
S. mutans cells at pH 6.0 with different substrate
concentrations: 5 ( ), 12,5 (*), 25 (×), 50 ( ), 125 ( ), and
250 ( ) µM. The bioluminescent reaction in cells was triggered by
the addition of different concentrations of D-luciferin,
and the light emission of the cells was immediately measured with a
microtitration plate luminometer. The values are the means of two
independent measurements. The variation between the measurements was
less than 10%. RLU, relative light units.
|
|
Effects of antimicrobial agents.
All antimicrobial agents
tested clearly inhibited both bacterial light emission and growth
on agar plates at the concentrations tested. The inhibition of light
emission was time (Table 4) and dose
(Fig. 5) dependent and was already seen
after 1 h of incubation but was more pronounced after 3 and 4 h. The MICs of chlorhexidine, tetracycline, and penicillin on agar
plates were 2.5, 0.8, and 0.025 µg/ml, respectively. The same
concentrations of chlorhexidine and penicillin affected both the light
emission and growth on agar plates, but lower concentrations of
tetracycline were needed to inhibit the light emission than to inhibit
growth.
View this table:
[in this window]
[in a new window]
|
TABLE 4.
Effects of various antimicrobial compounds on the
bioluminescence of recombinant S. mutans
sensor bacteriaa
|
|

View larger version (31K):
[in this window]
[in a new window]
|
FIG. 5.
Effects of different amounts of chlorhexidine ( ),
tetracycline ( ), and penicillin ( ) on the light emission
(relative light units [RLU]) of the bacteria. Twofold dilutions of
each antimicrobial agent were made, starting from 10.0 µg/ml for
chlorhexidine, 0.08 µg/ml for tetracycline, and 0.40 µg/ml for
penicillin (sample 6), and the antimicrobial agents were incubated with
the bacteria for 4 h at 35°C in BHI broth. The sample labelled 0 is the nontreated control. The values are the means of two independent
measurements. The variation between the measurements was less than
10%. Arrows indicate the concentrations that inhibited growth on agar
plates.
|
|
 |
DISCUSSION |
To our knowledge S. mutans strains have not
previously been transformed by electroporation, which in this
study was found to be a suitable method for the incorporation of
foreign DNA into strain NCTC 10449. The conditions similar to those
used with other streptococci (5) also functioned well with
S. mutans.
ATP is one of the substrates of the luciferase reaction, and each cell
contains a constant intracellular ATP pool which is effectively
regulated. The light emission in vivo is therefore a very sensitive
indicator of the intracellular state of the cells (26). We
have earlier shown that the substrate for the luciferase reaction does
not readily pass procaryotic or eucaryotic cell membranes at
physiological pH but is efficiently incorporated under slightly acidic
conditions in sodium citrate buffer (31), consistent with
the results of Wood and DeLuca (32). The optimum pH for
E. coli and Bacillus subtilis was shown to
be pH 5.0 (16). We tested here the penetration of
D-luciferin into S. mutans cells and found
the optimum to be at pH 6.0, in contrast to that for another
gram-positive bacterium, B. subtilis. At physiological pH
(pH 7.0) the substrate also penetrated the membranes of S. mutans cells.
The light emission of growing S. mutans cells
correlated well with the OD660 as well as the numbers of
CFU. However, the kinetics of in vivo bioluminescence were affected by
the growth phase. The older the cells became the faster the decay times
were, giving an indication of decreased intracellular ATP pools for the
luciferase reaction. We have shown earlier that E. coli
cloned with Vibrio harveyi luciferase genes luxA
and luxB emits bioluminescence at a level that is directly
proportional to the numbers of CFU, and hence, a linear relationship
can be obtained (11, 14). In the latter study the
minimum number of cells detected by their bioluminescent phenotype was
1,000. In this study the linear relationship of bioluminescence versus
CFU for the S. mutans cells was shown to give a
dynamic measurement range of over 4 logs, and the minimum amount
of cells detected over the background amount was roughly 30,000 cells.
The same shuttle plasmid construct, pCSS945, in E. coli
allows the detection of fewer than 100 cells, indicating that the phage
T5 promoter controlling insect luciferase expression is not as strong
in S. mutans as it is in E. coli. The
extremely high level of expression in E. coli is also
reflected in the very slow growth rate and the small colony size on
agar plates (unpublished data), but the moderate level of expression in
S. mutans keeps these cells in good physiological
condition, and hence, the effects of the different antimicrobial
treatments shown in this study are probably equal to those for the
non-plasmid-bearing cells. Moreover, since the physiological state of
the cells remains quite normal, it can be speculated that the cells
would also be useful in other studies of agents with activity against
streptococci, such as antiadherence studies. The ability of the
bacteria to adhere on the hard surfaces is thought to be one of the
virulence factors of mutans group streptococci, and the effects of
different treatments on the adherence properties of the bacteria are
generally studied by the method of Clark et al. (3) with
35S- or 3H-labelled bacteria. The
bioluminescent S. mutans phenotype could replace the
labelled bacteria, and thus, the use of the radiolabelled compounds in
obtaining the adherence measurements could be avoided.
The moderate level of expression can have an influence on the stability
of light emission. Cells kept in buffer at 0 or 4°C gave a rather
constant level of light emission rate during a prolonged incubation period. Analytically, this situation is good since reproducible and comparable results can be obtained from experiments performed during 1 working day. The higher storage temperatures (RT and
30°C) induced a rapid decrease in the light emission of the bacteria
which was probably due to a decrease in the cellular ATP content
(7) rather than the proteolytic degradation of the
luciferase enzyme or cell death.
An important factor in creating bioluminescent sensor cells is the
light emission kinetics as a function of substrate concentration and
pH. The decay of the bioluminescence of 0.6%/min at pH 6.0, as
measured for S. mutans in this study, is very
reasonable and simplifies the analytical performance of the assays. For
instance, it is possible for investigators to use a variety of
different light-measuring instruments, from fully automated
luminometers with substrate dispensers to liquid scintillation counters
with a slow rate of transfer of the measuring cuvette in front of the photomultiplier tube.
Luminescent E. coli has previously been used
successfully for the measurement of antibacterial activity
(29). The light-emitting S. mutans cells
also functioned well as biosensors of the antibacterial actions of the
antimicrobial agents tested. All antimicrobial agents tested, i.e.,
penicillin, chlorhexidine, and tetracycline, have different mechanisms
of action (12, 13), and especially with tetracycline, which
does not cause immediate cell death but which, instead, inhibits the
protein synthesis in a cell, lower concentrations clearly affected the
light emission but not the growth on the agar plates, indicating
disturbances in the intracellular state long before the actual growth
is inhibited. With chlorhexidine and penicillin, the bioluminescence
and agar plate results correlated well. Thus, the measurement of
bioluminescence was found to be a simple, fast, and reliable method for
the detection of the antibacterial effects of substances with different
mechanisms of action. Moreover, with bioluminescence measurements, the
kinetics of the antibacterial effect could also be followed.
However, the ATP content of the S. mutans cells, and
thus the emitted light, can decrease without affecting the viability of
the cells (6, 7). Thus, by measuring the light emission only, the actual killing of bacteria cannot be determined; rather, the
"well-being" of a cell is determined. Greger et al. (6) found that incubation of S. mutans cells in buffer (pH
5.0) with 1 mM sodium fluoride causes a rapid decrease in the cellular
ATP content but does not affect the viability for 4 h. We have
previously shown that in saliva at pH 5.0 such NaF concentrations
reduce the viability of S. mutans during 20 h of
incubation (20). We have also measured the light emission of
NaF-saliva-bacteria suspensions and found that the bioluminescence has
already decreased after 10 min of incubation, while the viability is
not affected during the first hours (unpublished data). Thus, a
decrease in ATP content does not inevitably cause immediate cell death,
but during longer incubation times, without a possibility of recovery,
cell death may occur.
To summarize, S. mutans NCTC 10449 cells were
found to be transformable by electroporation with a shuttle
vector (pCSS945) containing insect luciferase gene resulting in a
bioluminescent phenotype. The optimal conditions for light emission
by S. mutans were determined, and the bioluminescent
bacteria were found to be a versatile tool for the simple, rapid, and
sensitive screening of the antimicrobial activities of substances with
different mechanisms of action, for example, in human saliva.
 |
ACKNOWLEDGMENTS |
M. Virta is acknowledged for suggestions concerning using
luciferase genes for this study.
This study was supported by the Academy of Finland.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Institute
of Dentistry and Turku Immunology Centre, University of Turku,
Lemminkäisenkatu 2, FIN-20520 Turku, Finland. Phone:
358-2-3337918. Fax: 358-2-3338356. E-mail:
vuokko.loimaranta{at}utu.fi.
Present address: Department of Oral Medical and Surgical Sciences,
Faculty of Dentistry, University of British Columbia, Vancouver, British Columbia, Canada V6T 1Z3.
 |
REFERENCES |
| 1.
|
Biggley, W. H.,
J. E. Lloyd, and H. H. Seliger.
1967.
The spectral distribution of firefly light II.
J. Gen. Physiol.
50:1681-1692[Abstract/Free Full Text].
|
| 2.
|
Casabadan, M. J., and S. N. Cohen.
1978.
Analysis of gene control signals by DNA fusion and cloning in Escherichia coli.
J. Mol. Biol.
138:179-207.
|
| 3.
|
Clark, W. B.,
L. L. Bamman,
C. Greenall, and D. M. Kemeny.
1978.
Comparative estimates of bacterial affinities and adsorption sites on hydroxyapatite surfaces.
Infect. Immun.
19:1040-1047.
|
| 4.
|
Dower, W. J.,
J. F. Miller, and C. W. Ragsdale.
1988.
High efficiency transformation of E. coli by high voltage electroporation.
Nucleic Acids Res.
16:6126-6144.
|
| 5.
|
Dunny, G. M.,
L. N. Lee, and D. J. LeBlanc.
1991.
Improved electroporation and cloning vector system for gram-positive bacteria.
Appl. Environ. Microbiol.
57:1194-1201[Abstract/Free Full Text].
|
| 6.
|
Greger, J. E. G.,
E. J. Izaguirre-Fernandez, and A. D. Eisenberg.
1985.
Adenosine 5'-triphosphate content of Streptococcus mutans GS-5 during fluoride mediated death at low pH.
Caries Res.
19:307-313[Medline].
|
| 7.
|
Greger, J. E. G., and A. D. Eisenberg.
1985.
Adenosine 5'-trisphosphate content of Streptococcus mutans GS-5 during starvation in a buffered salt medium.
Caries Res.
19:314-319[Medline].
|
| 8.
|
Hill, P. J.,
G. S. A. B. Stewart, and P. E. Stanley.
1993.
Bioluminescence and chemiluminescence literature luciferase reporter genes lux and luc.
J. Biolumin. Chemilumin.
8:267-291[Medline].
|
| 9.
|
Jacobs, W. R., Jr.,
R. G. Barletta,
R. Udani,
J. Chan,
G. Kalkut,
G. Sosne,
T. Kieser,
G. J. Sarkis,
G. F. Hatfull, and B. R. Bloom.
1993.
Rapid assessment of drug susceptibilities of Mycobacterium tuberculosis by means of luciferase reporter phages.
Science
260:819-822[Abstract/Free Full Text].
|
| 10.
|
Karp, M.,
K. Åkerman,
C. Lindqvist,
A. Kuusisto,
P. Saviranta, and C. Oker-Blom.
1992.
A sensitive model system for in vivo monitoring of baculovirus gene expression in single infected insect cells.
Bio/Technology
10:565-569[Medline].
|
| 11.
|
Korpela, M., and M. Karp.
1988.
Stable-light producing Escherichia coli.
Biotechnol. Lett.
10:383-388.
|
| 12.
|
Kral, T. A., and M. D. Callaway.
1984.
Penicillin-induced lysis of Streptococcus mutans.
Infect. Immun.
46:442-447[Abstract/Free Full Text].
|
| 13.
|
Kuyyakanond, T., and L. B. Quesnel.
1992.
The mechanism of action of chlorhexidine.
FEMS Microbiol. Lett.
79:211-215[Medline].
|
| 14.
|
Lampinen, J.,
M. Korpela,
P. Saviranta,
R. Kroneld, and M. Karp.
1990.
Use of Escherichia coli cloned with genes encoding bacterial luciferase for evaluation of chemical toxicity.
Toxic. Assess.
5:337-350.
|
| 15.
|
Lampinen, J.,
L. Koivisto,
M. Wahlsten,
P. Mäntsälä, and M. Karp.
1992.
Expression of luciferase genes from different origins in Bacillus subtilis.
Mol. Gen. Genet.
232:498-504[Medline].
|
| 16.
|
Lampinen, J.
1995.
Development of recombinant bacterial strains for cytotoxicity testing. Ph.D. thesis. Ser. A1, Tom. 205.
University of Turku, Annales Universitatis Turkuensis, Turku, Finland.
|
| 17.
|
Lampinen, J.,
M. Virta, and M. Karp.
1995.
Comparison of gram positive and gram negative bacterial strains cloned with different types of luciferase genes in bioluminescence cytotoxicity tests.
Environ. Toxicol. Water Qual.
10:157-166.
|
| 18.
|
LeGrice, S. F. J.,
V. Beuck, and J. Mous.
1987.
Expression of biologically active human T-cell lymphotrophic virus type III reverse transcriptase in Bacillus subtilis.
Gene
55:95-103[Medline].
|
| 19.
|
Lenander-Lumikari, M.,
B. Månsson-Rahemtulla, and F. Rahemtulla.
1992.
Lysozyme enhances the inhibitory effects of the peroxidase system on glucose metabolism of Streptococcus mutans.
J. Dent. Res.
71:484-490[Abstract/Free Full Text].
|
| 20.
|
Lenander-Lumikari, M.,
V. Loimaranta,
S. Hannuksela,
J. Tenovuo, and J. Ekstrand.
1997.
Combined inhibitory effect of fluoride and hypothiocyanite on the viability and glucose metabolism of Streptococcus mutans, serotype c.
Oral Microbiol. Immunol.
12:231-235[Medline].
|
| 21.
|
Loesche, W. J.
1986.
Role of Streptococcus mutans in human dental decay.
Microbiol. Rev.
50:353-380[Free Full Text].
|
| 22.
|
Lumikari, M.,
T. Soukka,
S. Nurmio, and J. Tenovuo.
1991.
Inhibition of growth of Streptococcus mutans, S. sobrinus and Lactobacillus casei by oral peroxidase systems in human saliva.
Arch. Oral Biol.
36:155-160[Medline].
|
| 23.
|
McElroy, W. D., and H. H. Seliger.
1960.
Spectral emission and quantum yield of firefly bioluminescence.
Arch. Biochem. Biophys.
88:136[Medline].
|
| 24.
|
Seliger, H. H.,
J. B. Buck,
W. G. Fastie, and W. D. McElroy.
1964.
The spectral distribution of firefly light.
J. Gen. Physiol.
48:95-104[Abstract/Free Full Text].
|
| 25.
|
Soukka, T.,
M. Lumikari, and J. Tenovuo.
1991.
Combined inhibitory effect of lactoferrin and lactoperoxidase system on the viability of Streptococcus mutans, serotype c.
Scand. J. Dent. Res.
99:390-396[Medline].
|
| 26.
|
Stanley, P. E.
1989.
A review of bioluminescent ATP techniques in rapid microbiology.
J. Biolumin. Chemilumin.
4:375-380[Medline].
|
| 27.
|
Suvorov, A.,
J. Kok, and G. Venema.
1988.
Transformation of group A streptococci by electroporation.
FEMS Microbiol. Lett.
56:95-100.
|
| 28.
|
Tenovuo, J.,
Z. Moldoveanu,
J. Mestecky,
K. M. Pruitt, and B. Mansson-Rahemtulla.
1982.
Interaction of specific and innate factors of immunity: IgA enhances the antimicrobial effect of the lactoperoxidase system against Streptococcus mutans.
J. Immunol.
128:726-731[Abstract].
|
| 29.
|
Virta, M.,
M. Karp, and P. Vuorinen.
1994.
Nitric oxide donor-mediated killing of bioluminescent Escherichia coli.
Antimicrob. Agents Chemother.
38:2775-2779[Abstract/Free Full Text].
|
| 30.
|
Virta, M.,
J. Lampinen, and M. Karp.
1995.
A luminescence-based mercury biosensor.
Anal. Chem.
34:667-669.
|
| 31.
|
Virta, M.,
K. E. O. Åkerman,
P. Saviranta,
C. Oker-Blom, and M. T. Karp.
1995.
Real-time measurement of cell permeabilization with low-molecular weight membranolytic agents.
J. Antimicrob. Chemother.
36:303-315[Abstract/Free Full Text].
|
| 32.
|
Wood, K. V., and M. DeLuca.
1987.
Photographic detection of luminescence in Escherichia coli containing the gene for firefly luciferase.
Anal. Biochem.
161:501-507[Medline].
|
| 33.
|
Wood, K. V.,
Y. A. Lam,
H. H. Seliger, and W. D. McElroy.
1989.
Complementary DNA coding beetle luciferases can elicit bioluminescence of different colors.
Science
244:700-702[Abstract/Free Full Text].
|
Antimicrobial Agents and Chemotherapy, August 1998, p. 1906-1910, Vol. 42, No. 8
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Tong, H., Chen, W., Shi, W., Qi, F., Dong, X.
(2008). SO-LAAO, a Novel L-Amino Acid Oxidase That Enables Streptococcus oligofermentans To Outcompete Streptococcus mutans by Generating H2O2 from Peptone. J. Bacteriol.
190: 4716-4721
[Abstract]
[Full Text]
-
Kreth, J., Hung, D. C. I., Merritt, J., Perry, J., Zhu, L., Goodman, S. D., Cvitkovitch, D. G., Shi, W., Qi, F.
(2007). The response regulator ComE in Streptococcus mutans functions both as a transcription activator of mutacin production and repressor of CSP biosynthesis. Microbiology
153: 1799-1807
[Abstract]
[Full Text]
-
Merritt, J., Qi, F., Shi, W.
(2005). A unique nine-gene comY operon in Streptococcus mutans. Microbiology
151: 157-166
[Abstract]
[Full Text]
-
Kadurugamuwa, J. L., Sin, L. V., Yu, J., Francis, K. P., Kimura, R., Purchio, T., Contag, P. R.
(2003). Rapid Direct Method for Monitoring Antibiotics in a Mouse Model of Bacterial Biofilm Infection. Antimicrob. Agents Chemother.
47: 3130-3137
[Abstract]
[Full Text]
-
Kadurugamuwa, J. L., Sin, L., Albert, E., Yu, J., Francis, K., DeBoer, M., Rubin, M., Bellinger-Kawahara, C., Parr, T. R. Jr., Contag, P. R.
(2003). Direct Continuous Method for Monitoring Biofilm Infection in a Mouse Model. Infect. Immun.
71: 882-890
[Abstract]
[Full Text]
-
Tenovuo, J.
(2002). Antimicrobial Agents in Saliva--Protection for the Whole Body. J. Dent. Res.
81: 807-809
[Full Text]
-
Tenhami, M., Hakkila, K., Karp, M.
(2001). Measurement of Effects of Antibiotics in Bioluminescent Staphylococcus aureus RN4220. Antimicrob. Agents Chemother.
45: 3456-3461
[Abstract]
[Full Text]
-
Rogers, J. D., Palmer, R. J. Jr., Kolenbrander, P. E., Scannapieco, F. A.
(2001). Role of Streptococcus gordonii Amylase-Binding Protein A in Adhesion to Hydroxyapatite, Starch Metabolism, and Biofilm Formation. Infect. Immun.
69: 7046-7056
[Abstract]
[Full Text]
-
Rocchetta, H. L., Boylan, C. J., Foley, J. W., Iversen, P. W., LeTourneau, D. L., McMillian, C. L., Contag, P. R., Jenkins, D. E., Parr, T. R. Jr.
(2001). Validation of a Noninvasive, Real-Time Imaging Technology Using Bioluminescent Escherichia coli in the Neutropenic Mouse Thigh Model of Infection. Antimicrob. Agents Chemother.
45: 129-137
[Abstract]
[Full Text]
-
Salisbury, V., Pfoestl, A., Wiesinger-Mayr, H., Lewis, R., Bowker, K. E., MacGowan, A. P.
(1999). Use of a clinical Escherichia coli isolate expressing lux genes to study the antimicrobial pharmacodynamics of moxifloxacin. J Antimicrob Chemother
43: 829-832
[Abstract]
[Full Text]